nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCC3—lung cancer	0.186	0.526	CbGaD
Glyburide—ABCG2—lung cancer	0.0904	0.256	CbGaD
Glyburide—ALB—lung cancer	0.0394	0.111	CbGaD
Glyburide—ABCB1—lung cancer	0.0376	0.106	CbGaD
Glyburide—SLCO2B1—Erlotinib—lung cancer	0.0196	0.0443	CbGbCtD
Glyburide—ABCB11—Paclitaxel—lung cancer	0.0155	0.0351	CbGbCtD
Glyburide—ABCG2—Topotecan—lung cancer	0.0149	0.0337	CbGbCtD
Glyburide—ABCC3—Cisplatin—lung cancer	0.0144	0.0326	CbGbCtD
Glyburide—ABCC3—Etoposide—lung cancer	0.0142	0.0321	CbGbCtD
Glyburide—ABCG2—Gefitinib—lung cancer	0.0136	0.0308	CbGbCtD
Glyburide—ABCB11—Vinblastine—lung cancer	0.0136	0.0308	CbGbCtD
Glyburide—ABCG2—Teniposide—lung cancer	0.0132	0.0299	CbGbCtD
Glyburide—ABCC1—Paclitaxel—lung cancer	0.011	0.0249	CbGbCtD
Glyburide—ABCC1—Irinotecan—lung cancer	0.0109	0.0246	CbGbCtD
Glyburide—SLC22A7—Docetaxel—lung cancer	0.0102	0.0229	CbGbCtD
Glyburide—ABCC3—Doxorubicin—lung cancer	0.00968	0.0219	CbGbCtD
Glyburide—ABCC1—Vinblastine—lung cancer	0.00967	0.0218	CbGbCtD
Glyburide—ALB—Gefitinib—lung cancer	0.0094	0.0212	CbGbCtD
Glyburide—ABCC3—Methotrexate—lung cancer	0.00938	0.0212	CbGbCtD
Glyburide—ABCC1—Etoposide—lung cancer	0.00872	0.0197	CbGbCtD
Glyburide—ABCB11—Doxorubicin—lung cancer	0.00837	0.0189	CbGbCtD
Glyburide—ABCC2—Paclitaxel—lung cancer	0.00816	0.0184	CbGbCtD
Glyburide—ABCG2—Erlotinib—lung cancer	0.00806	0.0182	CbGbCtD
Glyburide—ABCC2—Irinotecan—lung cancer	0.00805	0.0182	CbGbCtD
Glyburide—ABCC1—Docetaxel—lung cancer	0.00797	0.018	CbGbCtD
Glyburide—ABCG2—Paclitaxel—lung cancer	0.00738	0.0167	CbGbCtD
Glyburide—SLC22A7—Methotrexate—lung cancer	0.00733	0.0166	CbGbCtD
Glyburide—ABCG2—Irinotecan—lung cancer	0.00728	0.0164	CbGbCtD
Glyburide—ABCC2—Vinblastine—lung cancer	0.00716	0.0162	CbGbCtD
Glyburide—ABCC2—Cisplatin—lung cancer	0.00657	0.0148	CbGbCtD
Glyburide—ABCC2—Etoposide—lung cancer	0.00645	0.0146	CbGbCtD
Glyburide—CYP2C19—Gefitinib—lung cancer	0.00609	0.0138	CbGbCtD
Glyburide—ABCC1—Doxorubicin—lung cancer	0.00594	0.0134	CbGbCtD
Glyburide—ABCG2—Cisplatin—lung cancer	0.00594	0.0134	CbGbCtD
Glyburide—CYP2C19—Teniposide—lung cancer	0.00591	0.0133	CbGbCtD
Glyburide—ABCC2—Docetaxel—lung cancer	0.0059	0.0133	CbGbCtD
Glyburide—ABCG2—Etoposide—lung cancer	0.00583	0.0132	CbGbCtD
Glyburide—ABCC1—Methotrexate—lung cancer	0.00576	0.013	CbGbCtD
Glyburide—ALB—Erlotinib—lung cancer	0.00556	0.0126	CbGbCtD
Glyburide—ABCB1—Topotecan—lung cancer	0.00538	0.0121	CbGbCtD
Glyburide—ABCG2—Docetaxel—lung cancer	0.00534	0.0121	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—lung cancer	0.00514	0.0116	CbGbCtD
Glyburide—CYP2C9—Gefitinib—lung cancer	0.00507	0.0114	CbGbCtD
Glyburide—ALB—Irinotecan—lung cancer	0.00502	0.0113	CbGbCtD
Glyburide—ABCB1—Gefitinib—lung cancer	0.00492	0.0111	CbGbCtD
Glyburide—CYP2C9—Teniposide—lung cancer	0.00491	0.0111	CbGbCtD
Glyburide—ABCC2—Doxorubicin—lung cancer	0.0044	0.00994	CbGbCtD
Glyburide—ABCC2—Methotrexate—lung cancer	0.00426	0.00962	CbGbCtD
Glyburide—ABCG2—Doxorubicin—lung cancer	0.00398	0.00898	CbGbCtD
Glyburide—ABCG2—Methotrexate—lung cancer	0.00385	0.0087	CbGbCtD
Glyburide—ABCB1—Vinorelbine—lung cancer	0.00379	0.00855	CbGbCtD
Glyburide—CYP3A4—Topotecan—lung cancer	0.00322	0.00727	CbGbCtD
Glyburide—SLC22A6—Methotrexate—lung cancer	0.00312	0.00704	CbGbCtD
Glyburide—ABCB1—Crizotinib—lung cancer	0.00301	0.00681	CbGbCtD
Glyburide—CYP3A4—Gefitinib—lung cancer	0.00295	0.00665	CbGbCtD
Glyburide—ABCB1—Gemcitabine—lung cancer	0.00295	0.00665	CbGbCtD
Glyburide—ABCB1—Erlotinib—lung cancer	0.00291	0.00657	CbGbCtD
Glyburide—CYP3A4—Teniposide—lung cancer	0.00286	0.00645	CbGbCtD
Glyburide—CYP2C9—Paclitaxel—lung cancer	0.00274	0.00619	CbGbCtD
Glyburide—ABCB1—Paclitaxel—lung cancer	0.00266	0.00601	CbGbCtD
Glyburide—ALB—Methotrexate—lung cancer	0.00266	0.006	CbGbCtD
Glyburide—ABCB1—Irinotecan—lung cancer	0.00263	0.00593	CbGbCtD
Glyburide—ABCC9—mammary gland—lung cancer	0.00254	0.084	CbGeAlD
Glyburide—ABCB1—Vinblastine—lung cancer	0.00233	0.00527	CbGbCtD
Glyburide—CYP3A4—Vinorelbine—lung cancer	0.00227	0.00512	CbGbCtD
Glyburide—KCNJ5—respiratory system—lung cancer	0.00223	0.0739	CbGeAlD
Glyburide—CYP2C9—Cisplatin—lung cancer	0.00221	0.00498	CbGbCtD
Glyburide—ABCB1—Cisplatin—lung cancer	0.00214	0.00483	CbGbCtD
Glyburide—ABCB1—Etoposide—lung cancer	0.0021	0.00475	CbGbCtD
Glyburide—ABCB1—Docetaxel—lung cancer	0.00192	0.00434	CbGbCtD
Glyburide—CYP3A4—Crizotinib—lung cancer	0.00181	0.00408	CbGbCtD
Glyburide—CYP3A4—Erlotinib—lung cancer	0.00174	0.00393	CbGbCtD
Glyburide—ABCA1—mammary gland—lung cancer	0.00172	0.057	CbGeAlD
Glyburide—CYP3A4—Paclitaxel—lung cancer	0.00159	0.0036	CbGbCtD
Glyburide—CYP3A4—Irinotecan—lung cancer	0.00157	0.00355	CbGbCtD
Glyburide—KCNJ5—cardiac atrium—lung cancer	0.00155	0.0513	CbGeAlD
Glyburide—ABCB1—Doxorubicin—lung cancer	0.00143	0.00324	CbGbCtD
Glyburide—CYP3A4—Vinblastine—lung cancer	0.0014	0.00316	CbGbCtD
Glyburide—ABCB1—Methotrexate—lung cancer	0.00139	0.00314	CbGbCtD
Glyburide—CYP3A4—Etoposide—lung cancer	0.00126	0.00285	CbGbCtD
Glyburide—KCNJ5—lung—lung cancer	0.00119	0.0392	CbGeAlD
Glyburide—CYP3A4—Docetaxel—lung cancer	0.00115	0.0026	CbGbCtD
Glyburide—ABCA1—respiratory system—lung cancer	0.00115	0.038	CbGeAlD
Glyburide—KCNJ11—mammary gland—lung cancer	0.0011	0.0363	CbGeAlD
Glyburide—CFTR—respiratory system—lung cancer	0.00108	0.0359	CbGeAlD
Glyburide—ABCC8—mammary gland—lung cancer	0.00101	0.0335	CbGeAlD
Glyburide—CFTR—epithelium—lung cancer	0.000906	0.03	CbGeAlD
Glyburide—ABCC9—lung—lung cancer	0.000899	0.0297	CbGeAlD
Glyburide—CFTR—bronchus—lung cancer	0.000893	0.0295	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—lung cancer	0.000859	0.00194	CbGbCtD
Glyburide—CFTR—trachea—lung cancer	0.000801	0.0265	CbGeAlD
Glyburide—SLCO2B1—mammary gland—lung cancer	0.000792	0.0262	CbGeAlD
Glyburide—ALB—mammary gland—lung cancer	0.000724	0.024	CbGeAlD
Glyburide—CPT1A—lung—lung cancer	0.000654	0.0216	CbGeAlD
Glyburide—ABCC9—lymph node—lung cancer	0.000615	0.0203	CbGeAlD
Glyburide—ABCA1—lung—lung cancer	0.00061	0.0202	CbGeAlD
Glyburide—SLC15A2—mammary gland—lung cancer	0.000605	0.02	CbGeAlD
Glyburide—CFTR—lung—lung cancer	0.000576	0.019	CbGeAlD
Glyburide—ABCC3—respiratory system—lung cancer	0.000566	0.0187	CbGeAlD
Glyburide—Gliclazide—VEGFA—lung cancer	0.000565	0.319	CrCbGaD
Glyburide—SLC15A1—epithelium—lung cancer	0.000539	0.0178	CbGeAlD
Glyburide—SLCO2B1—respiratory system—lung cancer	0.000528	0.0174	CbGeAlD
Glyburide—CYP2C9—mammary gland—lung cancer	0.000452	0.015	CbGeAlD
Glyburide—CPT1A—lymph node—lung cancer	0.000448	0.0148	CbGeAlD
Glyburide—ABCA1—lymph node—lung cancer	0.000417	0.0138	CbGeAlD
Glyburide—Zafirlukast—ABCG2—lung cancer	0.000404	0.229	CrCbGaD
Glyburide—SLC15A2—respiratory system—lung cancer	0.000403	0.0133	CbGeAlD
Glyburide—SLC15A2—bronchus—lung cancer	0.000332	0.011	CbGeAlD
Glyburide—ABCC1—bronchus—lung cancer	0.000328	0.0108	CbGeAlD
Glyburide—Zafirlukast—CYP2E1—lung cancer	0.000321	0.182	CrCbGaD
Glyburide—ABCC3—lung—lung cancer	0.000301	0.00994	CbGeAlD
Glyburide—SLC15A2—trachea—lung cancer	0.000298	0.00985	CbGeAlD
Glyburide—ABCC1—trachea—lung cancer	0.000294	0.00974	CbGeAlD
Glyburide—SLCO2B1—lung—lung cancer	0.00028	0.00926	CbGeAlD
Glyburide—ABCC1—cardiac atrium—lung cancer	0.000277	0.00915	CbGeAlD
Glyburide—KCNJ11—lymph node—lung cancer	0.000266	0.00879	CbGeAlD
Glyburide—SLCO1A2—lung—lung cancer	0.000258	0.00853	CbGeAlD
Glyburide—SLC15A2—lung—lung cancer	0.000214	0.00707	CbGeAlD
Glyburide—Bezafibrate—CYP1A1—lung cancer	0.000214	0.121	CrCbGaD
Glyburide—ABCC1—lung—lung cancer	0.000212	0.007	CbGeAlD
Glyburide—ABCC3—lymph node—lung cancer	0.000206	0.0068	CbGeAlD
Glyburide—ABCG2—bone marrow—lung cancer	0.000193	0.00639	CbGeAlD
Glyburide—SLCO2B1—lymph node—lung cancer	0.000192	0.00634	CbGeAlD
Glyburide—ALB—lymph node—lung cancer	0.000175	0.0058	CbGeAlD
Glyburide—ABCG2—lung—lung cancer	0.000175	0.00579	CbGeAlD
Glyburide—ABCC2—lymph node—lung cancer	0.000164	0.00543	CbGeAlD
Glyburide—ABCB1—respiratory system—lung cancer	0.000163	0.00538	CbGeAlD
Glyburide—Gliclazide—ALB—lung cancer	0.000152	0.0858	CrCbGaD
Glyburide—SLC15A2—lymph node—lung cancer	0.000146	0.00484	CbGeAlD
Glyburide—ABCC1—lymph node—lung cancer	0.000145	0.00478	CbGeAlD
Glyburide—ABCB1—epithelium—lung cancer	0.000136	0.0045	CbGeAlD
Glyburide—ABCB1—trachea—lung cancer	0.00012	0.00397	CbGeAlD
Glyburide—ABCG2—lymph node—lung cancer	0.00012	0.00396	CbGeAlD
Glyburide—Chlorpropamide—ABCB1—lung cancer	0.000113	0.0637	CrCbGaD
Glyburide—ABCB1—bone marrow—lung cancer	9.53e-05	0.00315	CbGeAlD
Glyburide—ABCB1—lung—lung cancer	8.64e-05	0.00286	CbGeAlD
Glyburide—Purpura—Doxorubicin—lung cancer	8.61e-05	0.000953	CcSEcCtD
Glyburide—Hypotension—Gemcitabine—lung cancer	8.61e-05	0.000952	CcSEcCtD
Glyburide—Eye disorder—Docetaxel—lung cancer	8.6e-05	0.000951	CcSEcCtD
Glyburide—Oedema—Cisplatin—lung cancer	8.59e-05	0.00095	CcSEcCtD
Glyburide—Vomiting—Topotecan—lung cancer	8.52e-05	0.000943	CcSEcCtD
Glyburide—Hypoglycaemia—Doxorubicin—lung cancer	8.51e-05	0.000941	CcSEcCtD
Glyburide—Paraesthesia—Irinotecan—lung cancer	8.49e-05	0.00094	CcSEcCtD
Glyburide—Leukopenia—Paclitaxel—lung cancer	8.46e-05	0.000936	CcSEcCtD
Glyburide—Rash—Topotecan—lung cancer	8.45e-05	0.000935	CcSEcCtD
Glyburide—Hypersensitivity—Vinorelbine—lung cancer	8.45e-05	0.000935	CcSEcCtD
Glyburide—Dermatitis—Topotecan—lung cancer	8.44e-05	0.000934	CcSEcCtD
Glyburide—Vomiting—Erlotinib—lung cancer	8.43e-05	0.000933	CcSEcCtD
Glyburide—Dyspnoea—Irinotecan—lung cancer	8.43e-05	0.000933	CcSEcCtD
Glyburide—Nervous system disorder—Cisplatin—lung cancer	8.42e-05	0.000932	CcSEcCtD
Glyburide—Thrombocytopenia—Cisplatin—lung cancer	8.41e-05	0.00093	CcSEcCtD
Glyburide—Headache—Topotecan—lung cancer	8.4e-05	0.000929	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Gemcitabine—lung cancer	8.39e-05	0.000929	CcSEcCtD
Glyburide—Rash—Erlotinib—lung cancer	8.36e-05	0.000925	CcSEcCtD
Glyburide—Dermatitis—Erlotinib—lung cancer	8.35e-05	0.000924	CcSEcCtD
Glyburide—Convulsion—Etoposide—lung cancer	8.35e-05	0.000924	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—lung cancer	8.33e-05	0.000922	CcSEcCtD
Glyburide—Dyspepsia—Irinotecan—lung cancer	8.32e-05	0.000921	CcSEcCtD
Glyburide—Headache—Erlotinib—lung cancer	8.31e-05	0.000919	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—lung cancer	8.3e-05	0.000919	CcSEcCtD
Glyburide—Hyperhidrosis—Cisplatin—lung cancer	8.3e-05	0.000918	CcSEcCtD
Glyburide—Paraesthesia—Gemcitabine—lung cancer	8.27e-05	0.000915	CcSEcCtD
Glyburide—Asthenia—Vinorelbine—lung cancer	8.23e-05	0.00091	CcSEcCtD
Glyburide—Decreased appetite—Irinotecan—lung cancer	8.22e-05	0.00091	CcSEcCtD
Glyburide—Dyspnoea—Gemcitabine—lung cancer	8.21e-05	0.000909	CcSEcCtD
Glyburide—Eosinophilia—Methotrexate—lung cancer	8.2e-05	0.000908	CcSEcCtD
Glyburide—Nausea—Vinblastine—lung cancer	8.2e-05	0.000907	CcSEcCtD
Glyburide—Convulsion—Paclitaxel—lung cancer	8.19e-05	0.000906	CcSEcCtD
Glyburide—Anorexia—Cisplatin—lung cancer	8.18e-05	0.000906	CcSEcCtD
Glyburide—Gastrointestinal disorder—Irinotecan—lung cancer	8.16e-05	0.000903	CcSEcCtD
Glyburide—Alopecia—Docetaxel—lung cancer	8.13e-05	0.0009	CcSEcCtD
Glyburide—Pancreatitis—Methotrexate—lung cancer	8.12e-05	0.000899	CcSEcCtD
Glyburide—Pruritus—Vinorelbine—lung cancer	8.11e-05	0.000898	CcSEcCtD
Glyburide—Myalgia—Paclitaxel—lung cancer	8.04e-05	0.00089	CcSEcCtD
Glyburide—Arthralgia—Paclitaxel—lung cancer	8.04e-05	0.00089	CcSEcCtD
Glyburide—Hypotension—Cisplatin—lung cancer	8.02e-05	0.000888	CcSEcCtD
Glyburide—Malnutrition—Docetaxel—lung cancer	8.01e-05	0.000886	CcSEcCtD
Glyburide—Erythema—Docetaxel—lung cancer	8.01e-05	0.000886	CcSEcCtD
Glyburide—Decreased appetite—Gemcitabine—lung cancer	8.01e-05	0.000886	CcSEcCtD
Glyburide—Nausea—Topotecan—lung cancer	7.96e-05	0.000881	CcSEcCtD
Glyburide—Gastrointestinal disorder—Gemcitabine—lung cancer	7.95e-05	0.00088	CcSEcCtD
Glyburide—Confusional state—Etoposide—lung cancer	7.93e-05	0.000878	CcSEcCtD
Glyburide—Nausea—Erlotinib—lung cancer	7.88e-05	0.000872	CcSEcCtD
Glyburide—Pancytopenia—Methotrexate—lung cancer	7.87e-05	0.000871	CcSEcCtD
Glyburide—Diarrhoea—Vinorelbine—lung cancer	7.84e-05	0.000868	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Cisplatin—lung cancer	7.82e-05	0.000866	CcSEcCtD
Glyburide—Feeling abnormal—Irinotecan—lung cancer	7.79e-05	0.000862	CcSEcCtD
Glyburide—Confusional state—Paclitaxel—lung cancer	7.78e-05	0.00086	CcSEcCtD
Glyburide—Gastrointestinal pain—Irinotecan—lung cancer	7.73e-05	0.000856	CcSEcCtD
Glyburide—Oedema—Paclitaxel—lung cancer	7.71e-05	0.000853	CcSEcCtD
Glyburide—Paraesthesia—Cisplatin—lung cancer	7.71e-05	0.000853	CcSEcCtD
Glyburide—Thrombocytopenia—Etoposide—lung cancer	7.7e-05	0.000852	CcSEcCtD
Glyburide—Dyspnoea—Cisplatin—lung cancer	7.65e-05	0.000847	CcSEcCtD
Glyburide—Hyperhidrosis—Etoposide—lung cancer	7.6e-05	0.000841	CcSEcCtD
Glyburide—Feeling abnormal—Gemcitabine—lung cancer	7.59e-05	0.00084	CcSEcCtD
Glyburide—Shock—Paclitaxel—lung cancer	7.59e-05	0.00084	CcSEcCtD
Glyburide—Nervous system disorder—Paclitaxel—lung cancer	7.56e-05	0.000837	CcSEcCtD
Glyburide—Photosensitivity reaction—Methotrexate—lung cancer	7.56e-05	0.000837	CcSEcCtD
Glyburide—Thrombocytopenia—Paclitaxel—lung cancer	7.55e-05	0.000836	CcSEcCtD
Glyburide—Anorexia—Etoposide—lung cancer	7.5e-05	0.00083	CcSEcCtD
Glyburide—Abdominal pain—Irinotecan—lung cancer	7.48e-05	0.000827	CcSEcCtD
Glyburide—Decreased appetite—Cisplatin—lung cancer	7.46e-05	0.000826	CcSEcCtD
Glyburide—Hyperhidrosis—Paclitaxel—lung cancer	7.46e-05	0.000825	CcSEcCtD
Glyburide—Gastrointestinal disorder—Cisplatin—lung cancer	7.41e-05	0.00082	CcSEcCtD
Glyburide—Anaemia—Docetaxel—lung cancer	7.4e-05	0.000819	CcSEcCtD
Glyburide—Anorexia—Paclitaxel—lung cancer	7.35e-05	0.000813	CcSEcCtD
Glyburide—Hypotension—Etoposide—lung cancer	7.35e-05	0.000813	CcSEcCtD
Glyburide—Vomiting—Vinorelbine—lung cancer	7.29e-05	0.000807	CcSEcCtD
Glyburide—Rash—Vinorelbine—lung cancer	7.23e-05	0.0008	CcSEcCtD
Glyburide—Dermatitis—Vinorelbine—lung cancer	7.22e-05	0.000799	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—lung cancer	7.22e-05	0.000799	CcSEcCtD
Glyburide—Hypotension—Paclitaxel—lung cancer	7.21e-05	0.000797	CcSEcCtD
Glyburide—Headache—Vinorelbine—lung cancer	7.18e-05	0.000795	CcSEcCtD
Glyburide—Leukopenia—Docetaxel—lung cancer	7.17e-05	0.000793	CcSEcCtD
Glyburide—Eosinophilia—Doxorubicin—lung cancer	7.1e-05	0.000786	CcSEcCtD
Glyburide—Feeling abnormal—Cisplatin—lung cancer	7.07e-05	0.000783	CcSEcCtD
Glyburide—Paraesthesia—Etoposide—lung cancer	7.06e-05	0.000782	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—lung cancer	7.03e-05	0.000778	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Paclitaxel—lung cancer	7.03e-05	0.000778	CcSEcCtD
Glyburide—Dyspnoea—Etoposide—lung cancer	7.01e-05	0.000776	CcSEcCtD
Glyburide—Hypersensitivity—Irinotecan—lung cancer	6.97e-05	0.000771	CcSEcCtD
Glyburide—Convulsion—Docetaxel—lung cancer	6.94e-05	0.000768	CcSEcCtD
Glyburide—Paraesthesia—Paclitaxel—lung cancer	6.92e-05	0.000766	CcSEcCtD
Glyburide—Agranulocytosis—Methotrexate—lung cancer	6.89e-05	0.000763	CcSEcCtD
Glyburide—Dyspnoea—Paclitaxel—lung cancer	6.88e-05	0.000761	CcSEcCtD
Glyburide—Decreased appetite—Etoposide—lung cancer	6.84e-05	0.000757	CcSEcCtD
Glyburide—Arthralgia—Docetaxel—lung cancer	6.82e-05	0.000755	CcSEcCtD
Glyburide—Myalgia—Docetaxel—lung cancer	6.82e-05	0.000755	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—lung cancer	6.81e-05	0.000754	CcSEcCtD
Glyburide—Nausea—Vinorelbine—lung cancer	6.81e-05	0.000754	CcSEcCtD
Glyburide—Gastrointestinal disorder—Etoposide—lung cancer	6.79e-05	0.000751	CcSEcCtD
Glyburide—Dyspepsia—Paclitaxel—lung cancer	6.79e-05	0.000751	CcSEcCtD
Glyburide—Asthenia—Irinotecan—lung cancer	6.78e-05	0.000751	CcSEcCtD
Glyburide—Decreased appetite—Paclitaxel—lung cancer	6.7e-05	0.000742	CcSEcCtD
Glyburide—Gastrointestinal disorder—Paclitaxel—lung cancer	6.66e-05	0.000737	CcSEcCtD
Glyburide—Hepatitis—Methotrexate—lung cancer	6.63e-05	0.000734	CcSEcCtD
Glyburide—Asthenia—Gemcitabine—lung cancer	6.61e-05	0.000731	CcSEcCtD
Glyburide—Confusional state—Docetaxel—lung cancer	6.59e-05	0.000729	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—lung cancer	6.55e-05	0.000725	CcSEcCtD
Glyburide—Oedema—Docetaxel—lung cancer	6.54e-05	0.000723	CcSEcCtD
Glyburide—Pruritus—Gemcitabine—lung cancer	6.52e-05	0.000721	CcSEcCtD
Glyburide—Feeling abnormal—Etoposide—lung cancer	6.48e-05	0.000717	CcSEcCtD
Glyburide—Diarrhoea—Irinotecan—lung cancer	6.47e-05	0.000716	CcSEcCtD
Glyburide—Gastrointestinal pain—Etoposide—lung cancer	6.43e-05	0.000712	CcSEcCtD
Glyburide—Shock—Docetaxel—lung cancer	6.43e-05	0.000712	CcSEcCtD
Glyburide—Nervous system disorder—Docetaxel—lung cancer	6.41e-05	0.000709	CcSEcCtD
Glyburide—Thrombocytopenia—Docetaxel—lung cancer	6.4e-05	0.000708	CcSEcCtD
Glyburide—Visual impairment—Methotrexate—lung cancer	6.39e-05	0.000707	CcSEcCtD
Glyburide—Feeling abnormal—Paclitaxel—lung cancer	6.36e-05	0.000703	CcSEcCtD
Glyburide—Hypersensitivity—Cisplatin—lung cancer	6.33e-05	0.0007	CcSEcCtD
Glyburide—Gastrointestinal pain—Paclitaxel—lung cancer	6.31e-05	0.000698	CcSEcCtD
Glyburide—Diarrhoea—Gemcitabine—lung cancer	6.3e-05	0.000697	CcSEcCtD
Glyburide—Urticaria—Etoposide—lung cancer	6.25e-05	0.000691	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—lung cancer	6.23e-05	0.00069	CcSEcCtD
Glyburide—Anorexia—Docetaxel—lung cancer	6.23e-05	0.00069	CcSEcCtD
Glyburide—Abdominal pain—Etoposide—lung cancer	6.22e-05	0.000688	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—lung cancer	6.2e-05	0.000686	CcSEcCtD
Glyburide—Asthenia—Cisplatin—lung cancer	6.16e-05	0.000682	CcSEcCtD
Glyburide—Urticaria—Paclitaxel—lung cancer	6.13e-05	0.000678	CcSEcCtD
Glyburide—Hypotension—Docetaxel—lung cancer	6.11e-05	0.000676	CcSEcCtD
Glyburide—Abdominal pain—Paclitaxel—lung cancer	6.1e-05	0.000675	CcSEcCtD
Glyburide—Vomiting—Irinotecan—lung cancer	6.01e-05	0.000665	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—lung cancer	5.97e-05	0.000661	CcSEcCtD
Glyburide—Rash—Irinotecan—lung cancer	5.96e-05	0.00066	CcSEcCtD
Glyburide—Dermatitis—Irinotecan—lung cancer	5.96e-05	0.000659	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Docetaxel—lung cancer	5.96e-05	0.000659	CcSEcCtD
Glyburide—Headache—Irinotecan—lung cancer	5.92e-05	0.000656	CcSEcCtD
Glyburide—ABCB1—lymph node—lung cancer	5.91e-05	0.00195	CbGeAlD
Glyburide—Diarrhoea—Cisplatin—lung cancer	5.87e-05	0.00065	CcSEcCtD
Glyburide—Paraesthesia—Docetaxel—lung cancer	5.87e-05	0.00065	CcSEcCtD
Glyburide—Alopecia—Methotrexate—lung cancer	5.86e-05	0.000648	CcSEcCtD
Glyburide—Vomiting—Gemcitabine—lung cancer	5.86e-05	0.000648	CcSEcCtD
Glyburide—Dyspnoea—Docetaxel—lung cancer	5.83e-05	0.000645	CcSEcCtD
Glyburide—Rash—Gemcitabine—lung cancer	5.81e-05	0.000643	CcSEcCtD
Glyburide—Dermatitis—Gemcitabine—lung cancer	5.8e-05	0.000642	CcSEcCtD
Glyburide—Hypersensitivity—Etoposide—lung cancer	5.79e-05	0.000641	CcSEcCtD
Glyburide—Malnutrition—Methotrexate—lung cancer	5.77e-05	0.000639	CcSEcCtD
Glyburide—Erythema—Methotrexate—lung cancer	5.77e-05	0.000639	CcSEcCtD
Glyburide—Headache—Gemcitabine—lung cancer	5.77e-05	0.000639	CcSEcCtD
Glyburide—Dyspepsia—Docetaxel—lung cancer	5.75e-05	0.000637	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—lung cancer	5.74e-05	0.000635	CcSEcCtD
Glyburide—Decreased appetite—Docetaxel—lung cancer	5.68e-05	0.000629	CcSEcCtD
Glyburide—Hypersensitivity—Paclitaxel—lung cancer	5.68e-05	0.000629	CcSEcCtD
Glyburide—Gastrointestinal disorder—Docetaxel—lung cancer	5.64e-05	0.000624	CcSEcCtD
Glyburide—Asthenia—Etoposide—lung cancer	5.64e-05	0.000624	CcSEcCtD
Glyburide—Nausea—Irinotecan—lung cancer	5.62e-05	0.000622	CcSEcCtD
Glyburide—Pruritus—Etoposide—lung cancer	5.56e-05	0.000616	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—lung cancer	5.53e-05	0.000612	CcSEcCtD
Glyburide—Asthenia—Paclitaxel—lung cancer	5.53e-05	0.000612	CcSEcCtD
Glyburide—Nausea—Gemcitabine—lung cancer	5.47e-05	0.000605	CcSEcCtD
Glyburide—Vomiting—Cisplatin—lung cancer	5.46e-05	0.000604	CcSEcCtD
Glyburide—Pruritus—Paclitaxel—lung cancer	5.46e-05	0.000604	CcSEcCtD
Glyburide—Vision blurred—Methotrexate—lung cancer	5.44e-05	0.000602	CcSEcCtD
Glyburide—Rash—Cisplatin—lung cancer	5.41e-05	0.000599	CcSEcCtD
Glyburide—Dermatitis—Cisplatin—lung cancer	5.41e-05	0.000598	CcSEcCtD
Glyburide—Feeling abnormal—Docetaxel—lung cancer	5.39e-05	0.000596	CcSEcCtD
Glyburide—Diarrhoea—Etoposide—lung cancer	5.38e-05	0.000596	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—lung cancer	5.37e-05	0.000594	CcSEcCtD
Glyburide—Gastrointestinal pain—Docetaxel—lung cancer	5.35e-05	0.000591	CcSEcCtD
Glyburide—Anaemia—Methotrexate—lung cancer	5.34e-05	0.00059	CcSEcCtD
Glyburide—Diarrhoea—Paclitaxel—lung cancer	5.28e-05	0.000584	CcSEcCtD
Glyburide—Abdominal pain—Docetaxel—lung cancer	5.17e-05	0.000572	CcSEcCtD
Glyburide—Leukopenia—Methotrexate—lung cancer	5.17e-05	0.000572	CcSEcCtD
Glyburide—Nausea—Cisplatin—lung cancer	5.1e-05	0.000564	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—lung cancer	5.07e-05	0.000561	CcSEcCtD
Glyburide—Convulsion—Methotrexate—lung cancer	5e-05	0.000553	CcSEcCtD
Glyburide—Vomiting—Etoposide—lung cancer	5e-05	0.000553	CcSEcCtD
Glyburide—Erythema—Doxorubicin—lung cancer	5e-05	0.000553	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—lung cancer	5e-05	0.000553	CcSEcCtD
Glyburide—Rash—Etoposide—lung cancer	4.96e-05	0.000549	CcSEcCtD
Glyburide—Dermatitis—Etoposide—lung cancer	4.95e-05	0.000548	CcSEcCtD
Glyburide—Headache—Etoposide—lung cancer	4.93e-05	0.000545	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—lung cancer	4.91e-05	0.000544	CcSEcCtD
Glyburide—Myalgia—Methotrexate—lung cancer	4.91e-05	0.000544	CcSEcCtD
Glyburide—Vomiting—Paclitaxel—lung cancer	4.9e-05	0.000543	CcSEcCtD
Glyburide—Rash—Paclitaxel—lung cancer	4.86e-05	0.000538	CcSEcCtD
Glyburide—Dermatitis—Paclitaxel—lung cancer	4.86e-05	0.000538	CcSEcCtD
Glyburide—Headache—Paclitaxel—lung cancer	4.83e-05	0.000535	CcSEcCtD
Glyburide—Hypersensitivity—Docetaxel—lung cancer	4.82e-05	0.000533	CcSEcCtD
Glyburide—Confusional state—Methotrexate—lung cancer	4.75e-05	0.000526	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—lung cancer	4.71e-05	0.000521	CcSEcCtD
Glyburide—Asthenia—Docetaxel—lung cancer	4.69e-05	0.000519	CcSEcCtD
Glyburide—Nausea—Etoposide—lung cancer	4.67e-05	0.000517	CcSEcCtD
Glyburide—Pruritus—Docetaxel—lung cancer	4.62e-05	0.000512	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—lung cancer	4.62e-05	0.000511	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—lung cancer	4.62e-05	0.000511	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—lung cancer	4.61e-05	0.00051	CcSEcCtD
Glyburide—Nausea—Paclitaxel—lung cancer	4.58e-05	0.000507	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—lung cancer	4.55e-05	0.000504	CcSEcCtD
Glyburide—Anorexia—Methotrexate—lung cancer	4.49e-05	0.000497	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—lung cancer	4.47e-05	0.000495	CcSEcCtD
Glyburide—Diarrhoea—Docetaxel—lung cancer	4.47e-05	0.000495	CcSEcCtD
Glyburide—Hypotension—Methotrexate—lung cancer	4.4e-05	0.000487	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—lung cancer	4.33e-05	0.000479	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methotrexate—lung cancer	4.29e-05	0.000475	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—lung cancer	4.26e-05	0.000471	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—lung cancer	4.26e-05	0.000471	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—lung cancer	4.23e-05	0.000468	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—lung cancer	4.2e-05	0.000465	CcSEcCtD
Glyburide—Vomiting—Docetaxel—lung cancer	4.16e-05	0.00046	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—lung cancer	4.15e-05	0.000459	CcSEcCtD
Glyburide—Rash—Docetaxel—lung cancer	4.12e-05	0.000456	CcSEcCtD
Glyburide—Dermatitis—Docetaxel—lung cancer	4.12e-05	0.000456	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—lung cancer	4.11e-05	0.000455	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—lung cancer	4.1e-05	0.000453	CcSEcCtD
Glyburide—Headache—Docetaxel—lung cancer	4.09e-05	0.000453	CcSEcCtD
Glyburide—Oedema—Doxorubicin—lung cancer	4.08e-05	0.000451	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—lung cancer	4.07e-05	0.00045	CcSEcCtD
Glyburide—Shock—Doxorubicin—lung cancer	4.01e-05	0.000444	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—lung cancer	4e-05	0.000443	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—lung cancer	3.99e-05	0.000442	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—lung cancer	3.94e-05	0.000436	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—lung cancer	3.89e-05	0.00043	CcSEcCtD
Glyburide—Nausea—Docetaxel—lung cancer	3.88e-05	0.00043	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—lung cancer	3.88e-05	0.00043	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—lung cancer	3.85e-05	0.000426	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—lung cancer	3.81e-05	0.000422	CcSEcCtD
Glyburide—Urticaria—Methotrexate—lung cancer	3.74e-05	0.000414	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—lung cancer	3.72e-05	0.000412	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.72e-05	0.000411	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—lung cancer	3.66e-05	0.000405	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—lung cancer	3.64e-05	0.000402	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—lung cancer	3.59e-05	0.000397	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—lung cancer	3.55e-05	0.000392	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—lung cancer	3.52e-05	0.00039	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—lung cancer	3.47e-05	0.000384	CcSEcCtD
Glyburide—Asthenia—Methotrexate—lung cancer	3.38e-05	0.000374	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—lung cancer	3.36e-05	0.000372	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—lung cancer	3.34e-05	0.000369	CcSEcCtD
Glyburide—Pruritus—Methotrexate—lung cancer	3.33e-05	0.000369	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—lung cancer	3.24e-05	0.000359	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—lung cancer	3.22e-05	0.000357	CcSEcCtD
Glyburide—Diarrhoea—Methotrexate—lung cancer	3.22e-05	0.000357	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—lung cancer	3.01e-05	0.000333	CcSEcCtD
Glyburide—Vomiting—Methotrexate—lung cancer	3e-05	0.000331	CcSEcCtD
Glyburide—Rash—Methotrexate—lung cancer	2.97e-05	0.000329	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—lung cancer	2.97e-05	0.000328	CcSEcCtD
Glyburide—Headache—Methotrexate—lung cancer	2.95e-05	0.000327	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—lung cancer	2.93e-05	0.000324	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—lung cancer	2.89e-05	0.000319	CcSEcCtD
Glyburide—Nausea—Methotrexate—lung cancer	2.8e-05	0.00031	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—lung cancer	2.79e-05	0.000309	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—lung cancer	2.59e-05	0.000287	CcSEcCtD
Glyburide—Rash—Doxorubicin—lung cancer	2.57e-05	0.000285	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—lung cancer	2.57e-05	0.000284	CcSEcCtD
Glyburide—Headache—Doxorubicin—lung cancer	2.56e-05	0.000283	CcSEcCtD
Glyburide—Nausea—Doxorubicin—lung cancer	2.42e-05	0.000268	CcSEcCtD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.91e-06	3.6e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTGS2—lung cancer	2.9e-06	3.58e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTT1—lung cancer	2.89e-06	3.57e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CG—lung cancer	2.87e-06	3.55e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.86e-06	3.54e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GCLC—lung cancer	2.85e-06	3.52e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP2A6—lung cancer	2.85e-06	3.52e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	2.84e-06	3.51e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCG2—lung cancer	2.83e-06	3.5e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ADCY1—lung cancer	2.83e-06	3.5e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CB—lung cancer	2.81e-06	3.47e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CD—lung cancer	2.8e-06	3.46e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.8e-06	3.46e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—lung cancer	2.78e-06	3.44e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HPGDS—lung cancer	2.78e-06	3.43e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ENO2—lung cancer	2.78e-06	3.43e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ENO1—lung cancer	2.77e-06	3.42e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP2E1—lung cancer	2.77e-06	3.42e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ALB—lung cancer	2.77e-06	3.42e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—APOA1—lung cancer	2.77e-06	3.42e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPP2R1B—lung cancer	2.76e-06	3.41e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.76e-06	3.41e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NQO1—lung cancer	2.74e-06	3.38e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—POMC—lung cancer	2.73e-06	3.37e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.73e-06	3.37e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.73e-06	3.37e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ENO1—lung cancer	2.7e-06	3.34e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—lung cancer	2.7e-06	3.34e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.7e-06	3.34e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MDM2—lung cancer	2.7e-06	3.33e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—RRM1—lung cancer	2.7e-06	3.33e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA3—lung cancer	2.7e-06	3.33e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTT1—lung cancer	2.7e-06	3.33e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—RAF1—lung cancer	2.69e-06	3.32e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.68e-06	3.31e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GCLC—lung cancer	2.67e-06	3.29e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP2A6—lung cancer	2.67e-06	3.29e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CREBBP—lung cancer	2.66e-06	3.29e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERBB2—lung cancer	2.66e-06	3.29e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.66e-06	3.28e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.65e-06	3.28e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MTOR—lung cancer	2.63e-06	3.24e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CB—lung cancer	2.63e-06	3.24e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD4—lung cancer	2.62e-06	3.24e-05	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	2.61e-06	3.23e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—lung cancer	2.6e-06	3.21e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—B4GALT5—lung cancer	2.54e-06	3.13e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	2.53e-06	3.13e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTEN—lung cancer	2.53e-06	3.12e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ENO1—lung cancer	2.53e-06	3.12e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CG—lung cancer	2.52e-06	3.12e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CD—lung cancer	2.52e-06	3.12e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.52e-06	3.11e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—lung cancer	2.49e-06	3.08e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP2E1—lung cancer	2.49e-06	3.07e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.48e-06	3.07e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—STK11—lung cancer	2.47e-06	3.05e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA4—lung cancer	2.47e-06	3.05e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NQO1—lung cancer	2.46e-06	3.04e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CB—lung cancer	2.44e-06	3.02e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—EP300—lung cancer	2.43e-06	3e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP2E1—lung cancer	2.43e-06	3e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—lung cancer	2.42e-06	3e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—lung cancer	2.42e-06	2.99e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—EP300—lung cancer	2.41e-06	2.98e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.41e-06	2.97e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA2—lung cancer	2.4e-06	2.97e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—POMC—lung cancer	2.4e-06	2.97e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NQO1—lung cancer	2.4e-06	2.96e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.38e-06	2.95e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SRC—lung cancer	2.36e-06	2.92e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CREBBP—lung cancer	2.34e-06	2.89e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA1—lung cancer	2.32e-06	2.87e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.32e-06	2.86e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—EP300—lung cancer	2.31e-06	2.86e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—lung cancer	2.3e-06	2.84e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCC3—lung cancer	2.29e-06	2.83e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	2.29e-06	2.83e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTP1—lung cancer	2.28e-06	2.82e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1A—lung cancer	2.27e-06	2.81e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NRAS—lung cancer	2.27e-06	2.8e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—lung cancer	2.27e-06	2.8e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP2E1—lung cancer	2.27e-06	2.8e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—lung cancer	2.26e-06	2.79e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NQO1—lung cancer	2.24e-06	2.77e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CAT—lung cancer	2.22e-06	2.75e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKR1C1—lung cancer	2.22e-06	2.74e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CD—lung cancer	2.22e-06	2.74e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—STK11—lung cancer	2.22e-06	2.74e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.21e-06	2.73e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CB—lung cancer	2.2e-06	2.72e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.19e-06	2.71e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—lung cancer	2.19e-06	2.71e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—lung cancer	2.19e-06	2.7e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—lung cancer	2.18e-06	2.69e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.17e-06	2.69e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK3—lung cancer	2.17e-06	2.69e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EP300—lung cancer	2.16e-06	2.67e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—STK11—lung cancer	2.16e-06	2.67e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCB1—lung cancer	2.16e-06	2.67e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—UGT1A1—lung cancer	2.16e-06	2.66e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—TYMS—lung cancer	2.12e-06	2.62e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—lung cancer	2.11e-06	2.61e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—SRC—lung cancer	2.1e-06	2.6e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTM1—lung cancer	2.1e-06	2.59e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.08e-06	2.57e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GNG11—lung cancer	2.08e-06	2.57e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTP1—lung cancer	2.05e-06	2.53e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—lung cancer	2.03e-06	2.51e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NRAS—lung cancer	2.02e-06	2.5e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—STK11—lung cancer	2.02e-06	2.5e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—EP300—lung cancer	2.01e-06	2.49e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTP1—lung cancer	2e-06	2.47e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CAT—lung cancer	1.99e-06	2.46e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP1A1—lung cancer	1.99e-06	2.46e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.98e-06	2.45e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALDOA—lung cancer	1.98e-06	2.45e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ERCC2—lung cancer	1.97e-06	2.44e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—lung cancer	1.95e-06	2.41e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CAT—lung cancer	1.95e-06	2.41e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCB1—lung cancer	1.94e-06	2.4e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK3—lung cancer	1.94e-06	2.39e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CB—lung cancer	1.93e-06	2.39e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOA3—lung cancer	1.92e-06	2.37e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—lung cancer	1.92e-06	2.37e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TYMS—lung cancer	1.91e-06	2.35e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—lung cancer	1.9e-06	2.35e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.9e-06	2.34e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—lung cancer	1.89e-06	2.33e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTM1—lung cancer	1.88e-06	2.33e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ADCY1—lung cancer	1.87e-06	2.31e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCG2—lung cancer	1.87e-06	2.31e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTP1—lung cancer	1.87e-06	2.31e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TYMS—lung cancer	1.86e-06	2.3e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—lung cancer	1.84e-06	2.28e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—lung cancer	1.84e-06	2.28e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTM1—lung cancer	1.84e-06	2.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HPGDS—lung cancer	1.83e-06	2.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ENO2—lung cancer	1.83e-06	2.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.82e-06	2.25e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CAT—lung cancer	1.82e-06	2.25e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—EP300—lung cancer	1.81e-06	2.24e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.81e-06	2.23e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—lung cancer	1.79e-06	2.22e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—lung cancer	1.79e-06	2.21e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1A1—lung cancer	1.79e-06	2.21e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—lung cancer	1.78e-06	2.2e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTT1—lung cancer	1.78e-06	2.2e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ERCC2—lung cancer	1.77e-06	2.19e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCB1—lung cancer	1.77e-06	2.19e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GCLC—lung cancer	1.76e-06	2.17e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2A6—lung cancer	1.76e-06	2.17e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1A1—lung cancer	1.74e-06	2.15e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—lung cancer	1.74e-06	2.15e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TYMS—lung cancer	1.74e-06	2.15e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—lung cancer	1.74e-06	2.15e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ERCC2—lung cancer	1.73e-06	2.14e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTM1—lung cancer	1.72e-06	2.12e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—lung cancer	1.71e-06	2.11e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOA1—lung cancer	1.71e-06	2.11e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—lung cancer	1.67e-06	2.07e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ENO1—lung cancer	1.67e-06	2.06e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—lung cancer	1.66e-06	2.05e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.63e-06	2.02e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1A1—lung cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ERCC2—lung cancer	1.61e-06	2e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—lung cancer	1.6e-06	1.98e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—EP300—lung cancer	1.59e-06	1.97e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—lung cancer	1.56e-06	1.92e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOA1—lung cancer	1.53e-06	1.89e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOA1—lung cancer	1.5e-06	1.85e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2E1—lung cancer	1.49e-06	1.85e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—lung cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—POMC—lung cancer	1.48e-06	1.83e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—lung cancer	1.48e-06	1.83e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NQO1—lung cancer	1.48e-06	1.83e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.47e-06	1.81e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—lung cancer	1.47e-06	1.81e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—lung cancer	1.46e-06	1.8e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CREBBP—lung cancer	1.44e-06	1.78e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—lung cancer	1.42e-06	1.75e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—lung cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—lung cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOA1—lung cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CD—lung cancer	1.37e-06	1.69e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—lung cancer	1.37e-06	1.69e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—lung cancer	1.34e-06	1.66e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.34e-06	1.65e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—STK11—lung cancer	1.33e-06	1.65e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—POMC—lung cancer	1.33e-06	1.64e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—lung cancer	1.31e-06	1.62e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—POMC—lung cancer	1.3e-06	1.61e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CREBBP—lung cancer	1.3e-06	1.6e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—lung cancer	1.28e-06	1.58e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CREBBP—lung cancer	1.27e-06	1.56e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTP1—lung cancer	1.23e-06	1.52e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CD—lung cancer	1.23e-06	1.52e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—lung cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—POMC—lung cancer	1.21e-06	1.5e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—lung cancer	1.21e-06	1.5e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CD—lung cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CAT—lung cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CB—lung cancer	1.19e-06	1.48e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—lung cancer	1.18e-06	1.46e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—lung cancer	1.18e-06	1.46e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CREBBP—lung cancer	1.18e-06	1.46e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—lung cancer	1.18e-06	1.46e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCB1—lung cancer	1.17e-06	1.44e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TYMS—lung cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTM1—lung cancer	1.13e-06	1.4e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CD—lung cancer	1.12e-06	1.39e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—lung cancer	1.11e-06	1.37e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—lung cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1A1—lung cancer	1.07e-06	1.33e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CB—lung cancer	1.07e-06	1.32e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ERCC2—lung cancer	1.06e-06	1.32e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—lung cancer	1.06e-06	1.31e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CB—lung cancer	1.05e-06	1.29e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—lung cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—lung cancer	1.03e-06	1.27e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—EP300—lung cancer	9.84e-07	1.22e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CB—lung cancer	9.77e-07	1.21e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—lung cancer	9.68e-07	1.2e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—lung cancer	9.63e-07	1.19e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—lung cancer	9.26e-07	1.14e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOA1—lung cancer	9.21e-07	1.14e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—lung cancer	9.04e-07	1.12e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—EP300—lung cancer	8.83e-07	1.09e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—EP300—lung cancer	8.62e-07	1.07e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—lung cancer	8.44e-07	1.04e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—lung cancer	8.41e-07	1.04e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—EP300—lung cancer	8.05e-07	9.95e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—POMC—lung cancer	8.01e-07	9.89e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CREBBP—lung cancer	7.8e-07	9.63e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CD—lung cancer	7.39e-07	9.14e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—lung cancer	7.3e-07	9.02e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—lung cancer	7.28e-07	8.99e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—lung cancer	6.53e-07	8.07e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CB—lung cancer	6.44e-07	7.96e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—lung cancer	6.39e-07	7.89e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—lung cancer	6.38e-07	7.88e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—lung cancer	5.96e-07	7.36e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—lung cancer	5.94e-07	7.35e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—lung cancer	5.57e-07	6.88e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—lung cancer	5.34e-07	6.59e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—EP300—lung cancer	5.31e-07	6.56e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—lung cancer	5.21e-07	6.44e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—lung cancer	4.87e-07	6.01e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—lung cancer	3.93e-07	4.85e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—lung cancer	3.21e-07	3.97e-06	CbGpPWpGaD
